You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cal-101

Showing 1 - 25 of 875
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, CAL-101)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Cologne, Germany
    German CLL Study Group
Apr 29, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of

Active, not recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +22 more
  • Scottsdale, Arizona
  • +1 more
Aug 10, 2021

Chronic Lymphocytic Leukemia Trial in Germany (Tirabrutinib, Idelalisib, Obinutuzumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Frankfurt, Brandenburg, Germany
  • +13 more
Dec 24, 2021

Acute Lymphoblastic Leukemia Trial in Spain (Idelalisib)

Terminated
  • Acute Lymphoblastic Leukemia
  • Badalona, Spain
  • +11 more
Sep 2, 2021

Chronic Lymphocytic Leukemia (CLL) Trial in Columbus, Salt Lake City (Idelalisib, BI 836826)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia (CLL)
  • Columbus, Ohio
  • +1 more
Nov 23, 2020

Chronic Lymphocytic Leukemia, Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Aichi, Miyagi, Tokyo (Idelalisib)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Aichi, Japan
  • +2 more
Feb 24, 2021

Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide

Completed
Has Results
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +2 more
  • Tafasitamab
  • +2 more
  • Jacksonville, Florida
  • +16 more
Dec 10, 2021

Previously Untreated Pancreatic Ductal Adenocarcinoma, Relapsed/Refractory Pancreatic Ductal Adenocarcinoma Trial in United

Terminated
Has Results
  • Previously Untreated Pancreatic Ductal Adenocarcinoma
  • Relapsed/Refractory Pancreatic Ductal Adenocarcinoma
  • Scottsdale, Arizona
  • +8 more
Mar 31, 2021

Myelofibrosis Trial in Stanford, Ann Arbor (Idelalisib, Ruxolitinib)

Terminated
Has Results
  • Myelofibrosis
  • Stanford, California
  • +1 more
Aug 31, 2020

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in United States (Entospletinib,

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • La Jolla, California
  • +12 more
May 18, 2020

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Follicular Lymphoma Trial in Worldwide (Idelalisib)

Active, not recruiting
  • Follicular Lymphoma
  • Woodville South, South Australia, Australia
  • +65 more
Aug 24, 2022

Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Lymphoma, Non-Hodgkin
  • Huntsville, Alabama
  • +17 more
Aug 22, 2019

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Portland (drug, device, biological)

Completed
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 21, 2020

Allergic Rhinitis Trial in Vienna (CAL-101, Placebo)

Completed
  • Allergic Rhinitis
  • CAL-101
  • Placebo
  • Vienna, Austria
    Vienna Challenge Chamber
Oct 19, 2018

Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Palo Alto, New York (Idelalisib)

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +3 more
  • Palo Alto, California
  • +1 more
Oct 19, 2018

Hodgkin Lymphoma Trial in New York, Houston, Seattle (Idelalisib)

Completed
Has Results
  • Hodgkin Lymphoma
  • New York, New York
  • +2 more
Oct 19, 2018

Platelet-Rich Fibrin Trial in Denizli (non surgical periodontal treatment)

Completed
  • Platelet-Rich Fibrin
  • non surgical periodontal treatment
  • Denizli, Deni̇zli̇, Turkey
    Gizem Torumtay Cin
Feb 22, 2023

Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

Not yet recruiting
  • Chronic Hepatitis b
  • Auckland, New Zealand
    New Zealand Clinical Research Auckland
Jul 26, 2023

Gynecologic Disease, Adnexal Mass, Adnexal Cyst Trial (Elective cystectomy, Elective oophorectomy, Elective salpingectomy)

Not yet recruiting
  • Gynecologic Disease
  • +10 more
  • Elective cystectomy
  • +3 more
  • (no location specified)
Mar 13, 2023

Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • KSD-101
  • Wuhan, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 19, 2023

Solid Tumor Trial in China (BPB-101)

Not yet recruiting
  • Solid Tumor
  • Guangzhou, Guangdong, China
  • +3 more
May 11, 2023

Frontotemporal Dementia, FTD, FTD-GRN Trial in Poland, Spain (Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101)

Recruiting
  • Frontotemporal Dementia
  • +3 more
  • Intrathalamic AAV.PGRN administration
  • Intrathalamic AVB-101
  • Katowice, Poland
  • +3 more
Oct 6, 2023

Gingivitis Trial in Cambridge (AMY-101, Water for injection)

Completed
  • Gingivitis
  • Cambridge, Massachusetts
    Forsyth Institute
Feb 19, 2021

Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -

Completed
  • Nonalcoholic Fatty Liver Disease
  • Anti-human CCL24 monoclonal antibody (CM-101) - Part One
  • +3 more
  • Jerusalem, Israel
    Hadassah University Hospital - Ein Kerem
Sep 13, 2023